Search

everythinglearnresearchcommunity

for

Search:↓

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Erythema multiforme-like lesions can occur in lupus without drug use or herpes infection.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Dupilumab may help treat alopecia areata without needing high IgE levels.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

QMSI effectively maps and quantifies drug distribution in skin tissues.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

The specific skin disease variant p.(Arg2000Trp) in plectin can cause a wide range of symptoms, which should be considered when diagnosing patients.

The treatment was effective for advanced non-Hodgkin's lymphomas.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

SLE should be considered in horses with immune-related skin issues.

Baricitinib is the most effective treatment for alopecia areata.

Blocking certain proteins on immune cells may help treat alopecia areata.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Low power red laser with efavirenz can reduce HIV-1 infection to undetectable levels and improve diagnosis.

Cell-based screening methods are useful and cost-effective for drug discovery but have pros and cons.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

CK 15, follistatin, and Bmi-1 can help differentiate basal cell carcinoma from squamous cell carcinoma.

Mogamulizumab can cause hair loss and skin rashes.